Literature DB >> 12379909

Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis.

Monica J Carson1.   

Abstract

Multiple sclerosis is a chronic demyelinating inflammatory disease of the central nervous system (CNS). As the tissue macrophage of the CNS, microglia have the potential to regulate and be regulated by cells of the CNS and by CNS-infiltrating immune cells. The exquisite sensitivity of microglia to these signals, coupled with their ability to develop a broad range of effector functions, allows the CNS to tailor microglial function for specific physiological needs. However, the great plasticity of microglial responses can also predispose these cells to amplify disproportionately the irrelevant or dysfunctional signals provided by either the CNS or immune systems. The consequences of such an event could be the conversion of self-limiting inflammatory responses into chronic neurodegeneration and may explain in part the heterogeneous nature of multiple sclerosis. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12379909      PMCID: PMC2693029          DOI: 10.1002/glia.10145

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   8.073


  109 in total

Review 1.  Glial cells in neurotoxicity development.

Authors:  M Aschner; J W Allen; H K Kimelberg; R M LoPachin; W J Streit
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

2.  Microglia stimulate naive T-cell differentiation without stimulating T-cell proliferation.

Authors:  M J Carson; J G Sutcliffe; I L Campbell
Journal:  J Neurosci Res       Date:  1999-01-01       Impact factor: 4.164

3.  Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy.

Authors:  G Moalem; R Leibowitz-Amit; E Yoles; F Mor; I R Cohen; M Schwartz
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

4.  Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis.

Authors:  B Bonetti; J Pohl; Y L Gao; C S Raine
Journal:  J Immunol       Date:  1997-12-01       Impact factor: 5.422

5.  Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor.

Authors:  H Neumann; T Misgeld; K Matsumuro; H Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

6.  Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo.

Authors:  W F Hickey; H Kimura
Journal:  Science       Date:  1988-01-15       Impact factor: 47.728

7.  Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus.

Authors:  J K Olson; A M Girvin; S D Miller
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

8.  Differential expression of costimulatory molecules B7-1 and B7-2 on microglial cells induced by Th1 and Th2 cells in organotypic brain tissue.

Authors:  S A Wolf; U Gimsa; I Bechmann; R Nitsch
Journal:  Glia       Date:  2001-12       Impact factor: 7.452

9.  Ligation of microglial CD40 results in p44/42 mitogen-activated protein kinase-dependent TNF-alpha production that is opposed by TGF-beta 1 and IL-10.

Authors:  J Tan; T Town; M Saxe; D Paris; Y Wu; M Mullan
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

10.  Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis.

Authors:  L Fan; C R Reilly; Y Luo; M E Dorf; D Lo
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

View more
  77 in total

Review 1.  Neuroinflammation in Huntington's disease.

Authors:  Thomas Möller
Journal:  J Neural Transm (Vienna)       Date:  2010-06-10       Impact factor: 3.575

Review 2.  CNS immune privilege: hiding in plain sight.

Authors:  Monica J Carson; Jonathan M Doose; Benoit Melchior; Christoph D Schmid; Corinne C Ploix
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

3.  Viral induction of central nervous system innate immune responses.

Authors:  J D Rempel; L A Quina; P K Blakely-Gonzales; M J Buchmeier; D L Gruol
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 4.  Role of microglia in multiple sclerosis.

Authors:  Xinqing Deng; Subramaniam Sriram
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

Review 5.  Microglia and the control of autoreactive T cell responses.

Authors:  Benoit Melchior; Shweta S Puntambekar; Monica J Carson
Journal:  Neurochem Int       Date:  2006-06-08       Impact factor: 3.921

6.  Tolerogenic effect of fiber tract injury: reduced EAE severity following entorhinal cortex lesion.

Authors:  Leman Mutlu; Christine Brandt; Erik Kwidzinski; Birgit Sawitzki; Ulrike Gimsa; Jacqueline Mahlo; Orhan Aktas; Robert Nitsch; Marloes van Zwam; Jon D Laman; Ingo Bechmann
Journal:  Exp Brain Res       Date:  2006-11-08       Impact factor: 1.972

Review 7.  IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease.

Authors:  Jarod Zepp; Ling Wu; Xiaoxia Li
Journal:  Trends Immunol       Date:  2011-04-12       Impact factor: 16.687

8.  Blockade of Glutamine Synthetase Enhances Inflammatory Response in Microglial Cells.

Authors:  Erika M Palmieri; Alessio Menga; Aurore Lebrun; Douglas C Hooper; D Allan Butterfield; Massimiliano Mazzone; Alessandra Castegna
Journal:  Antioxid Redox Signal       Date:  2016-11-02       Impact factor: 8.401

9.  Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation.

Authors:  Kiarash Riazi; Michael A Galic; J Brent Kuzmiski; Winnie Ho; Keith A Sharkey; Quentin J Pittman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-27       Impact factor: 11.205

Review 10.  CD4 T cells: Balancing the coming and going of autoimmune-mediated inflammation in the CNS.

Authors:  Bonnie N Dittel
Journal:  Brain Behav Immun       Date:  2008-01-18       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.